Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Michaela Liedtke, MD, of @StanfordMed, discusses #CARTcell #immunotherapy for #multiplemyeloma.Michaela Liedtke, MD, of @StanfordMed, discusses #CARTcell #immunotherapy for #multiplemyeloma.
Niels van de Donk, MD, PhD, Professor of Cancer Immunology, VU University Medical Center, Amsterdam, Netherlands, discusses #BCMA #CART therapy in #multiplemyeloma.
Part 1 – Case Presentation Welcome to the inaugural episode of the AML Clinical Case Series on The Doctor’s Channel! Gabriel N. Mannis, MD, presents the case of…
Part 2 – Case Discussion Gabriel N. Mannis, MD, discusses the case of patient “F.M.” with fellow faculty members Brian A. Jonas, MD, PhD, FACP, and Daniel A.…
Part 3 – Case Discussion & Wrap-up Gabriel N. Mannis, MD, discusses the case of patient “F.M.” with fellow faculty members Brian A. Jonas, MD, PhD, FACP, and…
